Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Taxing times in US as $194m-a-month device sales levy hits home

This article was originally published in Clinica

Executive Summary

Boston Scientific indicates that it will cost $75 million annually; for Stryker it will be $100 million: the cost to manufacturers of the 2.3% tax on US sales of most non-OTC medical devices, that is. Yesterday, reports said that the end-of-January first collection of the excise tax amounted to $97 million for the previous two weeks. It will average at $194 million per month in medical device tax payments to the IRS.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT099920

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel